Anixa Biosciences develops cancer therapies and vaccines, mainly for ovarian and breast cancer, and is based in San Jose, California. It last closed at $2.44 on Nov 20, down 6.15% on the day. For the quarter ended Jul 2026, ANIX reported EPS of -$0.08. Over the last 12 months ANIX insiders bought $522K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is ANIX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ANIX.
StreetAlpha's call on ANIXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ANIX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 20% below its 20 day and 17% below its 50 day average. It is 21% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot S1 at $2.36, and the nearest resistance the Pivot at $2.48.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 8.3%/day
Key levels
$5.4652 week high+123.8%
$3.09100 day average+26.6%
$2.95200 day average+20.9%
$2.9420 day average+20.5%
$2.8550 day average+16.8%
$2.82Swing high (Sep 21)+15.6%
$2.55Pivot R1+4.5%
$2.48Pivot+1.6%
$2.44Last close
$2.36Pivot S1−3.3%
$2.35Swing low (Jun 26)−3.7%
$2.3252 week low−4.9%
Indicators
RSI (14)
36.54
Weak, oversold below 30
Neutral
MACD
-0.10
Below its signal line
Bearish
Stochastic
11.8
Near the bottom of its range
Oversold
ADX (14)
20.4
Weak trend
Williams %R
-95.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-136.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−23.1%
Change over 10 sessions
Bearish
ATR (14)
$0.20
Typical daily range, 8.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 17.7%/day
Key levels
$5.4652 week high+123.8%
$3.09100 day average+26.6%
$2.95200 day average+20.9%
$2.9420 day average+20.5%
$2.8550 day average+16.8%
$2.82Swing high (Sep 21)+15.6%
$2.55Pivot R1+4.5%
$2.48Pivot+1.6%
$2.44Last close
$2.36Pivot S1−3.3%
$2.35Swing low (Jun 26)−3.7%
$2.3252 week low−4.9%
Indicators
RSI (14)
40.31
Middle of its range
Neutral
MACD
-0.09
Below its signal line
Bearish
Stochastic
18.1
Near the bottom of its range
Oversold
ADX (14)
13.0
No clear trend
Williams %R
-97.3
Oversold below −80, overbought above −20
Oversold
CCI (20)
-132.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.6%
Change over 10 sessions
Bearish
ATR (14)
$0.43
Typical daily range, 17.7% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ANIX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ANIX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow ANIX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ANIXHow many large options trades hit ANIX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ANIX in the last 90 days.
From SEC Form 4 filings by ANIX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANIX is in one of them and how their past ANIX trades turned out.
Anixa Biosciences is a biotechnology company based in San Jose, California, that is developing cancer therapies and vaccines. Its main programs focus on ovarian cancer and breast cancer, including a cell therapy designed to treat ovarian cancer and a vaccine aimed at preventing and treating breast cancer. Its products are still being tested in clinical trials and are not yet available for sale.